Arsenal Capital Partners has acquired Certara for an undisclosed amount.

Certara, headquartered in St. Louis, Mo., provides software and services to the biopharmaceutical research and development industry.

New York private equity firm Arsenal says the deal will expand the range of services the firm’s portfolio companies can provide. The firm is also invested in the Copernicus Group, IRB and IRBNet, which it combined into one company, WIRB-Copernicus Group, the provides biosafety services.

Arsenal focuses on investing in middle market specialty industrial and health care companies. The firm has about $1.7 billion in committed capital. In December, it bought Flowchem Ltd. and in July, it bought Adco Global Inc. to add to Royal Adhesives and Sealants LLC.

Certara was sold by San Francisco private equity firm Vector Capital, which focuses on investing in technology businesses.


 

William Blair & Co. LLC provided financial advice to Certara and Vector Capital, while Davis Polk & Wardwell LLP acted as legal counsel.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.